Table 3.
Cinobufacini group (n = 31) | Epirubicin group (n = 25) | P value | |
---|---|---|---|
Before treatment | 885 ± 931 | 596 ± 690 | 0.256 |
After treatment | 567 ± 749 | 571 ± 726 | 0.654 |
Cinobufacini group (n = 31) | Epirubicin group (n = 25) | P value | |
---|---|---|---|
Before treatment | 885 ± 931 | 596 ± 690 | 0.256 |
After treatment | 567 ± 749 | 571 ± 726 | 0.654 |